Aspen Aerogels (NYSE:ASPN) Stock Rating Upgraded by Zacks Research

Aspen Aerogels (NYSE:ASPN) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

A number of other research analysts also recently issued reports on the company. Barclays reduced their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a report on Friday, November 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Finally, Canaccord Genuity Group dropped their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $12.67.

Aspen Aerogels Stock Up 0.9%

Shares of NYSE:ASPN opened at $3.48 on Thursday. The stock has a market capitalization of $287.62 million, a P/E ratio of -0.94 and a beta of 2.94. The stock’s 50-day moving average price is $3.20 and its 200-day moving average price is $5.83. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28. Aspen Aerogels has a 12-month low of $2.80 and a 12-month high of $12.90.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The company had revenue of $73.02 million for the quarter, compared to analysts’ expectations of $73.42 million. Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The company’s revenue was down 37.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.17) earnings per share. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 56,845 shares of the firm’s stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the transaction, the chief executive officer owned 494,011 shares of the company’s stock, valued at approximately $1,595,655.53. This trade represents a 10.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ASPN. Royal Bank of Canada raised its position in Aspen Aerogels by 84.7% in the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock worth $360,000 after buying an additional 25,880 shares during the last quarter. AQR Capital Management LLC bought a new stake in shares of Aspen Aerogels in the first quarter worth approximately $960,000. Integrated Wealth Concepts LLC purchased a new position in shares of Aspen Aerogels during the first quarter valued at approximately $84,000. Goldman Sachs Group Inc. lifted its position in Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Caxton Associates LLP purchased a new stake in Aspen Aerogels in the first quarter worth approximately $307,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.